Method of treating HIV positive subjects
AssigneesConstantine Alen, Polexene Alen
InventorStavros Papadakis
Life of this patent
Estimating the term…
Abstract
A method of lowering p24 (HIV) antigen to not more than 40 picograms/ml in an HIV positive subject by the administration of a therapeutically active composition is disclosed. The composition includes as an active pharmaceutical an extract of at least one plant of the Asphodelus genus and the tenuifolius species or the chemical equivalent thereof. The plant extract includes an aqueous extract of a woody stem, a root system, a plurality of loculicidal capsules, and a plurality of seeds. The plant extract is admixed with a pharmaceutically acceptable carrier such as water.
Claims14
A composition for treating an HIV positive subject, having more than 40 picograms/ml of P24 (HIV) antigen comprising a mixture of an aqueous extract of an Asphodelus tenuifolius herb, cortisone and a pharmaceutically acceptable carrier.
A method of treating an HIV positive subject having a P24 (HIV) antigen of more than 40 picograms/ml to lower the P24 (HIV) antigen to not more than 40 picograms/ml which comprises administering to said HIV positive subject, a composition comprising an aqueous extract of at least one plant of Asphodelus tenuifolius and a pharmaceutically acceptable carrier.
A method of treating an HIV positive subject a P24 (HIV) antigen of more than 40 picograms to lower the P24 (HIV) antigen to not more than 40 picograms which comprises administering to said subject, a composition having an aqueous extract of at least one Asphodelus tenuifolius plant and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.